Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 185 of 5804
-
Personalized antibiotic strategy aims to prevent deadly infections after kidney transplant
Disease control Not yet recruitingKidney transplant recipients take medicines that suppress the immune system to prevent rejection of the transplanted kidney. As a result, they have a high risk of infections, especially urinary tract infections (UTIs). Some of these infections can spread to the bloodstream and ca…
Phase: PHASE3 • Sponsor: Susanne Dam Nielsen, MD, DMSc • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Could melatonin help kids with PTSD sleep better?
Symptom relief Not yet recruitingAmong the most sensitive and persistent symptoms of post-traumatic stress disorder (PTSD) in children are sleep disturbances in the insomnia spectrum (sleep onset disturbances, fragmented sleep with multiple nocturnal awakening, early morning awakening) as well as nightmares, aff…
Phase: PHASE3 • Sponsor: University Hospital, Strasbourg, France • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New trial aims to stop pneumonia in ventilated kids with nebulized antibiotic
Prevention Not yet recruitingThe goal of this clinical trial is to learn if nebulized colistimethate sodium can prevent pneumonia in ventilated children. The main question it aims to answer is: • Does nebulized colistimethate sodium lower the number of times participants develop ventilation associated pneum…
Phase: PHASE2, PHASE3 • Sponsor: University Hospital Fattouma Bourguiba • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
Skin-to-Skin cuddles may shield preemie brains from bleeding
Prevention Not yet recruitingThis clinical study aims to find out whether kangaroo care (skin-to-skin contact between parents and their extremely premature newborns) can help protect the babies' brains by reducing the risk of bleeding in the brain during the first days of life. To do this, the extremely prem…
Phase: NA • Sponsor: Hospital Universitario 12 de Octubre • Aim: Prevention
Last updated Jun 27, 2026 11:02 UTC
-
Major trial launches to find better treatments for Flesh-Eating parasite
Disease control Not yet recruitingMAMS4CL comprises a clinical trial with three embedded sub-studies designed to comprehensively evaluate the administered treatments and assess the impact of CL treatment on patients and the healthcare system. The multi-centre multi-arm multi-stage phase 3 clinical trial is desig…
Phase: PHASE3 • Sponsor: Institute of Tropical Medicine, Belgium • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Botox injections could replace surgery for kids with crossed eyes
Disease control Not yet recruitingChildhood esotropia (ET) is a common cause of visual disability, and its early management is critical for optimal visual and developmental outcomes. The proposed study addresses a need to evaluate botulinum toxin A (BTX-A) as a less invasive, cost-effective alternative to incisi…
Phase: PHASE3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Cord blood transfusions could be safer for preterm babies
Disease control Not yet recruitingAnemia is a condition in which there are not enough red blood cells to carry oxygen throughout the body. It is very common in extremely preterm infants (born before 28 weeks of pregnancy), and many of these babies require red blood cell transfusions during their hospital stay. C…
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Mailed test strips aim to slash opioid overdose deaths
Prevention Not yet recruitingThis Type 1 hybrid effectiveness-implementation randomized controlled trial, Remote Fentanyl Test Strip Distribution and Education to Prevent Drug Overdose, aims to address the United States opioid crisis driven by fentanyl and other synthetic opioids by reducing overdose rates. …
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Jul 03, 2026 00:00 UTC
-
Rwanda tests new way to diagnose breast cancer faster in rural areas
Diagnosis Not yet recruitingDiagnosing breast cancer early is critical to reduce preventable breast cancer deaths in sub-Saharan Africa. This can be done in part through increasing patients' access to breast ultrasound, which is essential for evaluating breast masses. However, ultrasound is typically provid…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 13:01 UTC
-
Magic mushroom therapy for depression? new trial tests psilocybin and CBT in groups
Symptom relief Not yet recruitingThis study will seek to determine the (1) acceptability and (2) feasibility of psilocybin as an adjunct to cognitive-behavioral therapy, delivered as a group treatment (G-PACBT) for major depressive disorder and (3) explore the clinical effects of G-PACBT on depressive symptoms a…
Phase: PHASE2 • Sponsor: University of California, Los Angeles • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could a 3-Step immune therapy save Insulin-Making cells in newly diagnosed type 1 diabetes?
Disease control Not yet recruitingThis study tests a three-phase immune treatment for people recently diagnosed with Type 1 diabetes (within 6 months, with some insulin production remaining). Phase 1 (weeks 1-2): Teplizumab, an anti-CD3 antibody, is given by infusion to slow immune attack on insulin-producing be…
Phase: PHASE1 • Sponsor: Abdullah Kars • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can a shingles vaccine and diabetes drug save insulin cells?
Disease control Not yet recruitingType 1 diabetes (T1D) is a chronic autoimmune disease characterized by progressive destruction of pancreatic beta cells mediated by autoreactive T lymphocytes, resulting in absolute insulin deficiency. Preservation of residual beta-cell function at the time of diagnosis is a crit…
Phase: PHASE2 • Sponsor: Ministry of Health, Saudi Arabia • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a $4 statin improve cancer survival?
Disease control Not yet recruitingEsophageal and gastroesophageal junction cancers are serious diseases with limited cure rates, even when patients receive chemotherapy and surgery. New ways to improve treatment are urgently needed. This study will test whether adding a commonly used cholesterol-lowering medicat…
Phase: PHASE2 • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New antibody shot could help babies beat HIV – trial launches
Disease control Not yet recruitingThe goal of this clinical trial is to learn if subcutaneous ePGT121v1-LS added to standard antiretroviral therapy (ART) is safe and helps improve HIV viral suppression in infants living with HIV in South Africa. The study will also learn how the body processes ePGT121v1-LS and wh…
Phase: PHASE1, PHASE2 • Sponsor: Hospital Universitario 12 de Octubre • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Brain bleed breakthrough? new drug could stop fluid buildup without surgery
Disease control Not yet recruitingHydrocephalus is a serious condition in which fluid builds up inside the brain, often requiring lifelong surgical placement of a shunt to drain excess cerebrospinal fluid (CSF). One of the most common causes of hydrocephalus is bleeding into the brain's fluid spaces after aneurys…
Phase: PHASE1, PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Experimental interferon boosts hopes for rectal cancer remission
Disease control Not yet recruitingThis is a multi-center, randomized, phase II study, aimed to evaluate the efficacy of investigational product at a dose of 1800 µg/day when given in combination with TNT. There will be two arms included in this study: Arm A (TNT regimen \+ 1800 µg/day of rSIFN-co treatment) and …
Phase: PHASE2 • Sponsor: Sichuan Huiyang Life Science and Technology Corporation • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New rapid tests aim to speed up ebola and lassa fever diagnosis
Diagnosis Not yet recruitingThis study aim to validate the clinical performances of two newly developed isothermal nucleic acid amplification bioassays modules for EBOV and LASV. Two retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already colle…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 04, 2026 00:00 UTC
-
New rapid ebola test could speed up outbreak detection
Diagnosis Not yet recruitingThis study aims to validate the clinical performance of a newly developed isothermal nucleic acid amplification bioassay module for EBOV. A retrospective studies will be conducted using biobanked patient samples such as plasma samples and buccal swabs already collected by the Ins…
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
Spinal fluid DNA test could personalize brain cancer therapy
Diagnosis Not yet recruitingThis prospective, single-center study will evaluate whether cerebrospinal fluid (CSF) circulating tumor DNA (ctDNA) testing using the Belay Summit assay can improve the clinical management of patients with malignant gliomas or brain metastases from non-small cell lung cancer (NSC…
Phase: NA • Sponsor: Alireza Mansouri • Aim: Diagnosis
Last updated Jul 10, 2026 00:00 UTC
-
Home workouts may ease Chemotherapy's toll on breast cancer patients
Symptom relief Not yet recruitingThe RE-CARE project is designed to evaluate the effects of a 24-week, remotely supervised, combined high-intensity interval aerobic and resistance exercise training on physical health and quality of life in patients with breast cancer (BC) undergoing neoadjuvant chemotherapy (NAC…
Phase: NA • Sponsor: Riga Stradins University • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC